cmAngio® vs inHEART Models

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by CureMetrix
VS
by inHEART

AI Verdict

Tool A focuses on identifying cardiovascular risk through breast arterial calcification detection on mammograms, aiding in early risk assessment for women. Tool B, conversely, creates detailed 3D heart models from CT/MR images to optimize planning and execution of cardiac ablation procedures. While both serve cardiology and radiology, their distinct applications target different stages of patient care, making them adjacent rather than direct competitors.

Choose cmAngio® if…

Choose cmAngio® if your primary objective is to enhance women's health screenings by integrating cardiovascular risk assessment into routine mammography. This AI software efficiently detects Breast Arterial Calcifications (BAC) on existing mammograms, providing valuable insights into a patient's cardiovascular health without requiring additional procedures or radiation.

View cmAngio® →

Choose inHEART Models if…

Choose inHEART Models if you need advanced, AI-driven 3D cardiac modeling to optimize the planning and execution of complex image-guided cardiac ablation procedures. This tool creates highly detailed digital twins of the heart from CT/MR images, enabling precise pre-procedural strategizing to potentially reduce procedure times and improve outcomes for conditions such as ventricular tachycardia.

View inHEART Models →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature cmAngio® inHEART Models
Pricing Paid, out-of-pocket Contact for pricing
Deployment Cloud-based, integrates with any DICOM-compliant viewer Cloud-based
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature cmAngio® inHEART Models
Name cmAngiou00ae inHEART Models
Company CureMetrix inHEART
Description FDA-cleared AI software for detecting Breast Arterial Calcifications (BAC) on mammograms, providing insights into cardiovascular health and aiding early risk assessment. AI-driven software that creates detailed 3D digital twin models of the heart from CT/MR images, optimizing planning and execution of image-guided cardiac ablation procedures.
Primary Specialty Cardiology, Obstetrics & Gynecology, Radiology Cardiology, Radiology
Key Feature 1 AI-based detection of Breast Arterial Calcifications (BAC) AI-driven digital twin of the heart
Key Feature 2 Processes both Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams Automated segmentation of CT and MR images

Videos

Demos, reviews, and walkthroughs featuring cmAngio® and inHEART Models.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

cmAngiou00ae by CureMetrix is designed for detecting Breast Arterial Calcifications (BAC) on mammograms, offering insights into cardiovascular health and aiding early risk assessment. inHEART Models, by inHEART, creates detailed 3D digital twin models of the heart from CT/MR images to optimize planning and execution of image-guided cardiac ablation procedures.
cmAngiou00ae processes both Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams. inHEART Models utilizes CT and MR images to generate its highly detailed, interactive 3D cardiac models.
cmAngiou00ae is compatible with any DICOM-compliant viewer and is designed for quick and easy installation. inHEART Models offers seamless integration with major electroanatomic mapping (EAM) systems, including Cartou00ae, Rhythmiau2122, Ensiteu2122, and Afferau2122.
cmAngiou00ae enables BAC identification and reporting without additional radiation or procedures, helping to identify women who might benefit from further cardiovascular evaluation. inHEART Models has the potential to reduce VT procedure times by 60% and VT recurrence rates by 38% through optimized pre-procedural planning for cardiac ablations.
cmAngiou00ae is relevant for Cardiology, Obstetrics & Gynecology, and Radiology specialties. inHEART Models is primarily designed for Cardiology and Radiology specialties.

Backers

Who funded each tool's parent company.

cmAngio®

AI Tool Finder
AI-powered search. Results may not be comprehensive.